source
- Western pharma firms lobby Trump administration to preserve China partnership opportunitiesWestern pharmaceutical companies are urging the Trump administration to permit continued collaborations with Chinese firms on promising drug candidates, despite a 2025 law that limits U.S. investme…
- Lexeo Therapeutics acquires Mantle Therapeutics for $8.3M to expand Friedreich ataxia pipelineLexeo Therapeutics announced it will acquire Mantle Therapeutics for an upfront payment of $8.3 million, aiming to broaden its Friedreich ataxia pipeline. The transaction could rise to $21.3 milli…